Position
ALGERT GLOBAL LLC in Rhythm Pharmaceuticals, Inc.
Back to the book · All holders of RYTM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.17K$0.11 → $0.09
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 88.3K | $9.45K | — | — | — | 0.1% |
| Q1 2026 | 58.5K | $5.09K | $0.09 | −$1.17K | −$3.18K | 0.1% |